CoLucid Pharmaceuticals, Inc.

Q2 2015 vs. Q3 2016 13F Holders

Period
Q2 2015
Q3 2016
Num holders
18
57
Total reported value, excl. options
$49.2 M
$472 M
Total shares, excl. options
5,524,520
12,373,266
Manager Q2 2015
Shares 		Q3 2016
Shares 		Diff Chg %